• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Pulmonary Arterial Hypertension (PAH) 
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for PAH trials.

DOWNLOAD BROCHURE GET IN TOUCH

Effective solutions for advancing PAH research

Pulmonary Arterial Hypertension (PAH) is a rare, progressive, vascular disease with high mortality and limited treatment options. Continued research is essential to bring hope to patients suffering from this disease. At Signant, we believe that with the right tools, researchers will gain the necessary understanding of diseases like PAH to advance treatments.

Why Signant Health

  • Administer Disease-Specific Questionnaires
  • Standardize PAH Assessments
  • Simplify Blinded Randomization
  • Alleviate Patient Concerns
  • Monitor Patients' Lifestyle
  • Administer Disease-Specific Questionnaires

    Administer Disease-Specific Questionnaires

    Signant SmartSignals eCOA makes it easy to administer quality-of-life, respiratory, and congested heart failure questionnaires – this includes the common KCCQ and SGRQ. The easy-to-use technology also eliminates the need to transcribe from paper and provides time-stamped, attributable data.
     
     
     
     

  • Standardize PAH Assessments

    Standardize PAH Assessments

    Standardizing PAH assessments across sites is essential to producing reliable data. Our in-house experts develop sponsor-specific videos for Signant’s Rater Training & Qualification to teach raters the proper methodologies when setting up a walking test course, counting laps, and administering supplemental oxygen.
     

     

  • Simplify Blinded Randomization

    Simplify Blinded Randomization

     Signant’s RTSM solution leverages proprietary algorithms to optimize drug supplies for blinded PAH studies. This digital IP management tool gives you complete control and optimal visibility of clinical supplies throughout your entire study.
     
     
     

  • Alleviate Patient Concerns

    Alleviate Patient Concerns

    Using multimedia to support various learning styles, Signant SmartSignals eConsent solution educates potential participants on study requirements, including the invasive procedures like cardiac catheterization. Patients can flag sections that need clarification and checks their comprehension to guarantee you capture a truly informed consent.
     
     
     
     

  • Monitor Patients' Lifestyle

    Monitor Patients' Lifestyle

    By integrating Actigraph sensors and wearables with our eCOA solution, you’ll gain continuous, real-time data on each patient’s sleep and activity patterns. This objective data will enhance your understanding of the disease’s and treatment’s impact on a patient’s quality of life. 
     
     
     

Comprehensive PAH experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our PAH trial resources
SOLUTION BROCHURE

PAH Trial Solutions Overview


GET INSIGHTS
VIDEO

PAH Trial Solutions


WATCH [2 MIN]
SOLUTION

Rater Training & Qualification

 
LEARN MORE

eClinical solutions for PAH Trials

Ready to learn more?

Discover how Signant can support your current or upcoming PAH trials. 

DOWNLOAD BROCHURE GET STARTED